All In MedTech

FDA Clearance Tracker · P210007-S008

Vivistim® Paired VNS System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 26, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P210007-S008
Device name
Vivistim® Paired VNS System
Applicant location
Austin, TX
Received
Nov 26, 2025
Decided
Feb 26, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P210007

Device type

Device class
Class III

Every decision under product code QPY

FDA's approval statement

As written in FDA's record.

Approval for expansion of MN Ops Center capabilities, including component receiving inspection & acceptance, in-house manufacturing and software installation of Stroke Application & Programming software (SAPS), routine software/firmware upgrades, and device relabeling.

Source documents

Other decisions for Mobia Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.